Literature DB >> 23381986

Invasive coinfection with Aspergillus and Mucor in a patient with acute myeloid leukemia.

Rui Bergantim1, Elisabete Rios, Fernanda Trigo, Jose Eduardo Guimarães.   

Abstract

The authors report the case of a 58-year-old female patient with a life-threatening invasive fungal disease caused by a coinfection of Aspergillus and Mucor species that occurred during induction and consolidation chemotherapy for an acute myeloid leukemia. The disease was successfully treated with an aggressive therapeutic approach, which consisted of liposomal amphotericin B in combination with surgical exploration without compromising the treatment of her underlying disease. The case demonstrates the difficulties associated with establishing a diagnosis as well as the need for close observation to identify these infections, which are often misdiagnosed and only suspected late during the course of the disease. Doubts about the reliability of the diagnostic tools lead to uncertainties with regard to the choice of first-line drugs as well the selection of the most appropriate therapeutic strategy in hematologic patients.

Entities:  

Mesh:

Year:  2013        PMID: 23381986     DOI: 10.1007/s40261-012-0022-4

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  18 in total

1.  Case reports. Secondary prophylaxis with liposomal amphotericin B after invasive aspergillosis following treatment for haematological malignancy.

Authors:  L Mele; L Pagano; F Equitani; G Leone
Journal:  Mycoses       Date:  2001       Impact factor: 4.377

2.  Prophylaxis of invasive fungal diseases in patients with hematologic disorders.

Authors:  Corrado Girmenia
Journal:  Haematologica       Date:  2010-10       Impact factor: 9.941

Review 3.  Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies.

Authors:  Nikolaos V Sipsas; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2006-04-24       Impact factor: 9.079

4.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

5.  Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.

Authors:  Oliver A Cornely; Angelika Böhme; Dieter Buchheidt; Hermann Einsele; Werner J Heinz; Meinolf Karthaus; Stefan W Krause; William Krüger; Georg Maschmeyer; Olaf Penack; Jörg Ritter; Markus Ruhnke; Michael Sandherr; Michal Sieniawski; Jörg-Janne Vehreschild; Hans-Heinrich Wolf; Andrew J Ullmann
Journal:  Haematologica       Date:  2008-12-09       Impact factor: 9.941

Review 6.  Current therapeutic approaches to fungal infections in immunocompromised hematological patients.

Authors:  Livio Pagano; Morena Caira; Caterina Giovanna Valentini; Brunella Posteraro; Luana Fianchi
Journal:  Blood Rev       Date:  2010-01-06       Impact factor: 8.250

7.  Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

Authors:  Catherine Cordonnier; Cécile Pautas; Sébastien Maury; Anne Vekhoff; Hassan Farhat; Felipe Suarez; Nathalie Dhédin; Francoise Isnard; Lionel Ades; Frédérique Kuhnowski; Françoise Foulet; Mathieu Kuentz; Patrick Maison; Stéphane Bretagne; Michaël Schwarzinger
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

8.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 9.  Fungal infections in leukemia patients: how do we prevent and treat them?

Authors:  Konstantinos Leventakos; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

Review 10.  ZYGOMYCOSIS: current approaches to management of patients with haematological malignancies.

Authors:  Livio Pagano; Caterina G Valentini; Morena Caira; Luana Fianchi
Journal:  Br J Haematol       Date:  2009-05-18       Impact factor: 6.998

View more
  6 in total

Review 1.  Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature.

Authors:  Maddalena Chermetz; Margherita Gobbo; Katia Rupel; Giulia Ottaviani; Giancarlo Tirelli; Rossana Bussani; Roberto Luzzati; Roberto Di Lenarda; Matteo Biasotto
Journal:  Mycopathologia       Date:  2016-06-27       Impact factor: 2.574

Review 2.  Mini Review: Risk Assessment, Clinical Manifestation, Prediction, and Prognosis of Mucormycosis: Implications for Pathogen- and Human-Derived Biomarkers.

Authors:  Jaime David Acosta-España; Kerstin Voigt
Journal:  Front Microbiol       Date:  2022-06-20       Impact factor: 6.064

3.  A long-term survivor of disseminated Aspergillus and mucorales infection: an instructive case.

Authors:  Setareh Davoudi; Paolo Anderlini; Gregory N Fuller; Dimitrios P Kontoyiannis
Journal:  Mycopathologia       Date:  2014-08-03       Impact factor: 2.574

Review 4.  COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.

Authors:  Yasmine Benhadid-Brahmi; Samia Hamane; Benjamin Soyer; Alexandre Mebazaa; Alexandre Alanio; Benjamin Chousterman; Stéphane Bretagne; Sarah Dellière
Journal:  J Mycol Med       Date:  2021-11-26       Impact factor: 2.391

5.  Successful Management of Mixed Mycosis in HIV-Negative Patients With Different Immune Status: A Case Series Report.

Authors:  Yangqing Zhan; Chun Lu; Shaoqiang Li; Jin Zhao; Zhengtu Li; Yingying Gu; Feng Ye
Journal:  Front Cell Infect Microbiol       Date:  2022-03-04       Impact factor: 5.293

6.  Difficult diagnosis of invasive fungal infection predominantly involving the lower gastrointestinal tract in acute lymphoblastic leukaemia.

Authors:  Gulhadiye Avcu; Deniz Yilmaz Karapinar; Pinar Yazici; Muhterem Duyu; Suleyha Hilmioglu Polat; Berna Atabay; Basak Doganavsargil; Bulent Karapinar
Journal:  Med Mycol Case Rep       Date:  2016-01-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.